Equity
Compensation
Executive Compensation for Pharma, Biopharma & Med Tech Sales & Commercial Leaders
Equity compensation in life sciences is rarely simple. Between incentive stock options, RSUs, ESPPs, and nonqualified deferred compensation plans, executives in pharmaceutical, biopharma, and medical technology companies face decisions that can significantly impact their long-term wealth, and get it wrong just as easily.
Just as three generations of experience have shaped how we protect and grow our clients’ assets, that same generational expertise informs how we guide executives through the complexities of equity compensation, balancing today’s decisions against the legacy you’re building for tomorrow. Our approach includes:
Stock Option, RSU & ESPP Strategy
We help you evaluate exercise timing, tax implications, and diversification strategy so your equity compensation works toward your broader financial goals, not against them.
Deferred Compensation Planning
Nonqualified deferred comp plans carry unique risks and opportunities. We help you weigh election timing, distribution planning, and how these benefits integrate with your overall retirement and tax strategy.
Concentrated Stock Position Management
A large equity stake in your employer can mean outsized risk. We build strategies to manage concentration risk while being mindful of tax consequences, blackout periods, and insider trading considerations.
